RAP 0.00% 20.5¢ resapp health limited

2020 commercialisation, page-51

  1. 26,533 Posts.
    lightbulb Created with Sketch. 1722
    Supposedly the telehealth providers in Europe are still "looking under the hood", I guess they are still observing how the patient (not necessarily the numbers) and clinician experience are finding ResAppDx-EU......from the director of the respiratory clinic and Apps Store reviews (if they are real), it's been received very well. Only a matter of when and not if....IMO.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.